drugset / Trial / NCT05530226

A Single Arm Study of Traditional Chinese Medicine for Plasma Cell Mastitis

NCT05530226

Phase 2 Unknown 50 enrolled Shengjing Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a single-center, single-arm, open-label trial evaluating the efficacy and safety of traditional Chinese medicine for plasma cell mastitis.

Timeline

Start
2021-10-01
Primary completion
2022-10-31
Completion
2023-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Traditional Chinese Medicine Traditional medicine (herbal / TCM) Oral

Indications